Enhanced Recovery Program After Laparoscopic Colon Cancer Surgery
NCT ID: NCT02399631
Last Updated: 2018-01-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
180 participants
INTERVENTIONAL
2012-01-31
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Rehabilitation Following Laparoscopic Colonic Surgery
NCT00938210
ERAS in Laparoscopic Surgery for Colorectal Cancer: Risk Factors for Delayed Recovery
NCT02527967
Benefit of Rehabilitation Program in Colorectal Surgery
NCT01609361
Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol in Gastric Surgery for Cancer
NCT03865810
Intracorporeal Versus Extracorporeal Anastomosis In Laparoscopic Right Colon Resection
NCT05077358
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ERAS group
early recovery program with no preoperative mechanical bowel preparation, early diet initiation, and prevention of postoperative ileus after elective laparoscopic colon cancer surgery
Enhanced recovery program
Enhanced recovery program day-1: no mechanical bowel preparation, intake permit until 6 hrs before operation day0: operation, postoperative fluid therapy, antibiotics day1: liquid diet, early ambulation, removal of foley catheterization day2-3: soft diet day 4-5: discharge
Congrol group
Traditional, conventional perioperative treatment
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Enhanced recovery program
Enhanced recovery program day-1: no mechanical bowel preparation, intake permit until 6 hrs before operation day0: operation, postoperative fluid therapy, antibiotics day1: liquid diet, early ambulation, removal of foley catheterization day2-3: soft diet day 4-5: discharge
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ECOG 0-2
* Pathologically diagnosed colon cancer
* Stage I-III
* No functional disturbance in liver, kidney, bone marrow
* Informed consent
Exclusion Criteria
* Obstructive or perforated cancer
* Rectosigmoid or rectal cancer
* Synchronous tumor
* Uncontrolled psychiatric or neurologic problems
* Severe hepatic dysfunction (GOT, GPT ≥100IU/L)
* Renal dysfunction (Cr ≥2mg/dl)
* Recent MI, CVA, nitrate medication
20 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kyungpook National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gyu-Seog Choi
Director, Head of colorectal cancer center, Principal Investigator, Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gyu-Seog Choi, MD
Role: STUDY_CHAIR
Kyunpook National Univercity Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gyu seog Choi
Daegu, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KNUHCRC005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.